Ultragenyx Pharmaceutical(MX:RARE)
MX$256.000.00 (0.00%)
MX:RARE
Ultragenyx Pharmaceutical earnings date
MX$256.00
At close:0.00 (0.00%)
Ultragenyx Pharmaceutical (RARE) Q1 2024 Earnings Report
1 Followers
MX:RARE Q1 2024 EPS Results
- Actual EPS
- -MXN 38.83
- Consensus EPS
- -MXN 33.42
- Beat/Miss
- Missed by -MXN 5.41
- One Year Ago EPS
- -MXN 44.57
MX:RARE Q1 2024 Revenue Results
- Actual Revenue
- MXN 2.08B
- Expected Revenue
- MXN 2.22B
- Beat/Miss
- Missed by -MXN 137.73M
- YoY Revenue Growth
- +8.30%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/02/2024
- Time
- After Close
- Conference Call
- Thursday, May 2, 2024
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2024 Earnings Call Audio
MX:RARE Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 45.28- | -24.68 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -21.04-22.19 | -34.62 | 35.91% (+12.43) | |
| Aug 04, 2026 | 2026 (Q2) | -23.76-17.22 | -22.38 | 23.08% (+5.16) | |
| May 05, 2026 | 2026 (Q1) | -28.46-35.20 | -30.03 | -17.20% (-5.16) | |
| Feb 12, 2026 | 2025 (Q4) | -20.91-24.68 | -26.59 | 7.19% (+1.91) | |
| Nov 04, 2025 | 2025 (Q3) | -23.61-34.62 | -26.78 | -29.29% (-7.84) | |
| Aug 05, 2025 | 2025 (Q2) | -24.81-22.38 | -29.08 | 23.03% (+6.70) | |
| May 06, 2025 | 2025 (Q1) | -30.57-30.03 | -38.83 | 22.66% (+8.80) | |
| Feb 13, 2025 | 2024 (Q4) | -25.02-26.59 | -29.08 | 8.55% (+2.49) | |
| Nov 05, 2024 | 2024 (Q3) | -28.39-26.78 | -42.66 | 37.22% (+15.88) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


